Novartis to scale up data science under AI deal with Oxford

Novartis AG (NYSE:NVS; SIX:NOVN) and the University of Oxford's Big Data Institute (BDI) will use artificial intelligence to analyze ultra large and multiple data sets from Novartis' drug development programs to identify

Read the full 322 word article

User Sign In